MedTrace Logo

Mild Cognitive Impairment in Breast Cancer Patients

NCT01949376 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2020-04-03

No results posted yet for this study

Summary

The purpose of this study is to improve our understanding of potential changes in size, shape and activity in some brain areas that can occur in women receiving different types of Breast Cancer therapy, and how these changes are related to the development of mild cognitive impairment as the result of these treatments.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Lei Wang, PhD · Northwestern University

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01949376 on ClinicalTrials.gov